One-side-coated insert as a unique ophthalmic drug delivery system

被引:24
作者
Sasaki, H
Nagano, T
Sakanaka, K
Kawakami, S
Nishida, K
Nakamura, J
Ichikawa, N
Iwashita, J
Nakamura, T
Nakashima, M
机构
[1] Nagasaki Univ, Sch Med, Dept Hosp Pharm, Nagasaki 8528501, Japan
[2] Santen Pharmaceut Co Ltd, Nara Res & Dev Ctr, Ikoma 6300101, Japan
[3] Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki 8528521, Japan
关键词
drug delivery system; one-side-coated insert; pharmacokinetics; beta-blocker;
D O I
10.1016/S0168-3659(03)00362-6
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
We newly prepared a unique one-side-coated insert that releases drug from only uncoated side. The purpose of this study is to determine whether ocular and systemic absorption of ophthalmic drug could be altered by an inserting direction of the insert in rabbit eyes. One-side-coated insert was prepared by attaching a polypropylene tape on the one side of the polymer disc of poly(2-hydroxypropyl methacrylate) (HPM) containing tilisolol as a model ophthalmic drug. The insert was applied in the lower conjunctival cul-de-sac of albino rabbits with the uncoated side facing bulbar conjunctiva/sclera (SC insert) or palpebral conjunctiva (CJ insert). At the adequate intervals, the tear fluid, plasma, aqueous humor, conjunctiva, and sclera were collected and the drug concentrations were determined by an HPLC. A release of tilisolol from the one-side-coated insert was twice slower than from the uncoated insert. Ocular application of the one-side-coated insert produced the constant concentrations of tilisolol in the tear fluid over 180 min. SC insert showed higher drug concentrations in the aqueous humor and sclera, and lower drug concentrations in the plasma and conjunctiva than CJ insert. The one-side-coated insert can alter the ocular and systemic absorption of drug by an inserting direction. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:241 / 247
页数:7
相关论文
共 21 条
[1]   PHYSICOCHEMICAL DETERMINANTS OF DRUG DIFFUSION ACROSS THE CONJUNCTIVA, SCLERA, AND CORNEA [J].
AHMED, I ;
GOKHALE, RD ;
SHAH, MV ;
PATTON, TF .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1987, 76 (08) :583-586
[2]   DISPOSITION OF TIMOLOL AND INULIN IN THE RABBIT EYE FOLLOWING CORNEAL VERSUS NON-CORNEAL ABSORPTION [J].
AHMED, I ;
PATTON, TF .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1987, 38 (1-3) :9-21
[3]   Clinical evaluation of bioadhesive ophthalmic drug inserts (BODI®) for the treatment of external ocular infections in dogs [J].
Baeyens, V ;
Felt-Baeyens, O ;
Rougier, S ;
Pheulpin, S ;
Boisramé, B ;
Gurny, R .
JOURNAL OF CONTROLLED RELEASE, 2002, 85 (1-3) :163-168
[4]   Relevance of polymer molecular weight to the in vitro/in vivo performances of ocular inserts based on poly(ethylene oxide) [J].
Di Colo, G ;
Burgalassi, S ;
Chetoni, P ;
Fiaschi, MP ;
Zambito, Y ;
Saettone, MF .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2001, 220 (1-2) :169-177
[5]   PENETRATION ROUTES OF TOPICALLY APPLIED EYE MEDICATIONS [J].
DOANE, MG ;
JENSEN, AD ;
DOHLMAN, CH .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1978, 85 (03) :383-386
[6]   Poly(2-hydroxyethyl methacrylate) film as a drug delivery system for pilocarpine [J].
Hsiue, GH ;
Guu, JA ;
Cheng, CC .
BIOMATERIALS, 2001, 22 (13) :1763-1769
[7]  
Ishii Y, 2002, J CLIN PHARMACOL, V42, P1020
[8]  
Kaur IP, 2002, DRUG DEV IND PHARM, V28, P473
[9]   LIMITS ON OPTIMIZING OCULAR DRUG DELIVERY [J].
KEISTER, JC ;
COOPER, ER ;
MISSEL, PJ ;
LANG, JC ;
HAGER, DF .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1991, 80 (01) :50-53
[10]   Ophthalmic drug delivery systems - Recent advances [J].
Le Bourlais, C ;
Acar, L ;
Zia, H ;
Sado, PA ;
Needham, T ;
Leverge, R .
PROGRESS IN RETINAL AND EYE RESEARCH, 1998, 17 (01) :33-58